S-Ketamin ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
298Hereditary pancreatitis1

298. Hereditary pancreatitis


Clinical trials : 95 Drugs : 148 - (DrugBank : 51) / Drug target genes : 53 - Drug target pathways : 142
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2013-003357-17-DK
(EUCTR)
01/11/201304/11/2013The Ketamine - a novel approach to treating painful chronic pancreatitis.RESET TrialA randomized, double-blinded, single-centre, parallel-group, placebo-controlled, prospective trial of S-ketamine for pain treatment in chronic pancreatitis (RESET trial) - RESET Trial Chronic Pancreatitis
MedDRA version: 17.1;Level: LLT;Classification code 10009093;Term: Chronic pancreatitis;System Organ Class: 100000004856
MedDRA version: 17.1;Level: HLT;Classification code 10033646;Term: Acute and chronic pancreatitis;System Organ Class: 100000004856;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Trade Name: S-Ketamin
Product Name: S-ketamin
Trade Name: Midazolam
Product Name: Midazolam
Prof. Asbjørn Mohr DrewesNULLNot RecruitingFemale: yes
Male: yes
60Phase 4Denmark